- Seqens plans to invest in a second isopropanol production plant in Roussillon, France.
- The new unit will have a capacity of 50,000 metric tons per year and start up in 2021.
- This expansion will increase Seqens' global IPA production capacity by over 70%.
- The plant will also boost production of isopropyl acetate (IPAC) and diisopropyl ether (DIPE).
Investment in New Isopropanol Plant
Seqens, a key player in high-value oxygenated solvents, is set to invest in a second production plant for isopropanol (IPA) at the Roussillon chemical platform in France. This new facility will increase Seqens' global annual IPA production capacity by more than 70%, adding 50,000 metric tons per year. The plant is scheduled to start operations in 2021.
Optimized Production Process
The new unit will benefit from an optimized production process, leveraging the experience gained from Seqens' first production unit. It will also have competitive access to raw materials and energy supplied by the Roussillon platform.
Meeting Growing Demand
This investment will enable Seqens to meet the increasing demand for IPA, including new high-end applications. The additional capacity will also support the production of several downstream specialty products such as isopropyl acetate (IPAC) and diisopropyl ether (DIPE).
Applications of IPA, IPAC, and DIPE
Isopropanol (IPA) is a versatile solvent used in various industrial and consumer products, including pharmaceuticals, cosmetics, personal care, electronics, and detergents. Isopropyl acetate (IPAC) is used as a process solvent and in the extraction of organic products, with key applications in the production of active pharmaceutical ingredients, inks for food packaging, and cosmetics actives. Diisopropyl ether (DIPE) is a high-value solvent used in the pharmaceutical industry for manufacturing specific active ingredients and plays a crucial role in producing coatings, resins, intermediates, and high-purity phosphoric acid.
